Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluate Persistence of Immune Response of GSK Biologicals' TWINRIX Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 Years at Time of First Vaccine Dose.

Next Previous
X
Search
Trial Profile

Evaluate Persistence of Immune Response of GSK Biologicals' TWINRIX Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 Years at Time of First Vaccine Dose.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis A-hepatitis B vaccine (Primary)
  • Indications Hepatitis A; Hepatitis B
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Sponsors GSK

    • Most Recent Events

    • 27 Oct 2008 Actual end date changed Jul 2008 to Jun 2004 as reported by ClinicalTrials.gov.
    • 09 Sep 2008 Additional trial identifiers 100566,100567,100568,100569,100570 added as reported by ClinicalTrials.gov.
    • 09 Sep 2008 Primary endpoint identified as antibody level as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top